Extended indication |
Extension of indication to include treatment of adults with X-linked hypophosphataemia (XLH), and modification of the currently approved indication in children and adolescents, by removing the qualification ‘with growing skeletons’, in order to include treatment in all children with radiographic evidence of bone disease.
|